stockrow
Monday 9 November 2026
Export AGMB’s income statement to Excel — free account
AgomAb Therapeutics NV
AGMB
7.64
0.67
+9.61%
Follow AGMB
Alert me
AgomAb Therapeutics NV (AGMB) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SRZN Surrozen, Inc. compare | n/m |
| IRD Opus Genetics, Inc. compare | n/m |
| OBIO Orchestra BioMed Holdings, Inc. compare | n/m |
| AVIR Atea Pharmaceuticals, Inc. compare | n/m |
| CTNM Contineum Therapeutics, Inc. compare | n/m |
| RZLT Rezolute, Inc. compare | n/m |
| AUTL Autolus Therapeutics PLC Sponsored ADR compare | n/m |
| MPLT MapLight Therapeutics, Inc. compare | n/m |
| AGMB AgomAb Therapeutics NV | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)